This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Gladys Keitany, PhD
Associate Director, BCR/Antibody Discovery at Adaptive Biotechnologies


Gladys Keitany, PhD, is an immunologist with over 15 years of experience and an expert in B cell Biology and antibody discovery. Her role at adaptive has associate director of antibody discovery is focused on identifying rare highly potent antibodies to both infectious diseases and autoimmune diseases using adaptive high throughput pairseg technology. Gladys earned her PhD in pathobiology and parasitology from University of Washington in Seattle, WA, working on identifying vaccine candidates in malaria. She later did her postdoc on development of antigen specific B cells and impact of drug treatment in the liver stage of malaria parasite.

Agenda Sessions

  • Robust Production of Antibody Fragments and Their Therapeutic Applications/Applying High Throughput Novel Pairing Technology to Discover Diverse Native Antibodies from Bulk B Cells